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The G H secretory status of children with disordered growth has been the focus of numerous investigations. Many such studies have assessed endogenous G H levels in children with short stature. Some short children have abnormalities of circulating C H concentration profiles according to some (1-6) but not other investigators (7, 8) . The apparent discrepancies between these studies include issues such as the inclusion of different control groups; use of an objective, validated hormone pulse detection program; and the use of different G H assays. Any or all of these factors, as well as others, may contribute to the differing results.
The mechanism(s) subserving the observed alterations of serum G H concentration profiles in children with subnormal growth are not known. As such, none of the studies described has assessed specific variations in G H secretion and metabolic clearance. T o assess alterations in either secretion or clearance, we have used the technique of deconvolution analysis (9) in a group of children with previously defined abnormalities of endogenous C H concentrations. Deconvolution analysis, or convolution modeling, represents a mathematical technique that, when applied to hormone data series, provides subject-specific estimates of the neurosecretory events and of hormone clearance (10, 11) . Assuming that G H secretion occurs in a repetitive, burst-like fashion, convolution modeling characterizes these bursts of pituitary hormone release by their frequency of occurrence, the mass of hormone secreted, the rate of hormone secretion, and the duration of the secretory process. Estimates of hormone production and subject-specific clearance rates can be derived simultaneously from deconvolution analysis. The results of our analysis provide new insight into the altered G H physiology that characterizes some short prepubertal males with constitutional delay of growth.
SUBJECTS A N D METHODS
Subjects. Thirty-one prepubertal children were enrolled in this study. None had received prior treatment with growth promoting agents. All participants had prepubertal sexual development. None had evidence of systemic disease, intrauterine growth retardation, dysmorphic features, or previous CNS irradiation. Body mass indices (12) were within t-2.0 SDS for skeletal age G H SECRETION IN SHOR T PREPUBERTAL MALES   279 for all subjects. The clinical characteristics of all subjects have been reported previously (6) .
Thirteen healthy boys with a height SDS of -2.0 or less composed the SHORT group. All had BA within f 2.0 SDS based on chronologic age. The SHORT-DBA group was composed of seven healthy male subjects with a height SDS of -2.0 or less and bone age SDS of -2.0 or less for chronologic age. Subjects in both the SHORT and SHORT-DBA groups had G H concentrations of > 10 ~lg/L after pharmacologic testing. Eleven healthy males composed the NORMAL group. All had height SDS, weight SDS, and BA SDS within f 2.0 for chronologic age.
Auxologic measurements were normalized according to the data of Tanner and Davies (1 3). Pubertal staging was based on genital development according to the method of Marshall and Tanner (14) . Skeletal maturation and SDS were determined according to the method of Tanner et a/. (1 5).
Protocol. The study was approved by the Human Investigation Committee at the University of Virginia and was performed in at institution's General Clinical Research Center. Participants were informed of the details of the investigation. Legal consent and assent were then provided by the parents or legal guardians and the children, respectively.
An i.v. catheter with heparin lock was inserted into a forearm vein at least 2 h before sampling. Venous blood samples were obtained every 20 min via the indwelling catheter beginning at 2000 h and continuing through 0800 h. Subjects were allowed normal activity and were provided caffeine-free meals and snacks.
Assays. Serum G H concentrations were determined in duplicate by an immunoradiometric assay (Nichols Institute, San Juan Capistrano, CA) using the supplied horse-serum matrix. The limit of assay detection is 0.5 ~lg/L with intra-and interassay coefficients of variation of 58.0 and 510.0%, respectively. All samples obtained from a given subject were measured in a single assay run to avoid interassay variability. Plasma IGF-I concentrations were determined using a double-antibody RIA kit (Nichols Institute).
Deconvolution analysis. Based on the premise that GH and other anterior pituitary hormones are secreted in a burst-like fashion and that hormone elimination occurs at subject-specific metabolic clearance rates (9), we used deconvolution analysis to estimate the following dynamic measures of G H secretion and removal: I ) number and positions in time of the secretory episodes, 2) secretory burst half-duration (duration of the secretory episode at half-maximal amplitude), 3) amplitude (maximal secretory rate in each secretory burst, and 4) G H half-life corresponding to a disappearance rate constant. Multiple-parameter deconvolution analysis assumes that the simultaneous operation of these four sets of parameters gives rise to the circulating G H concentrations (9). The mass of G H secreted per episode was calculated as the integral (area) of the deconvolution-resolved secretory burst. The 12-h G H production rate was calculated as the product of the average mass of hormone secreted per burst and the total number of secretory bursts. An assumption of multiple-parameter deconvolution analysis is that each secretory burst can be approximated statistically by a gaussian distribution of release rates. No constitutive secretion was necessary to model the present experimental data.
Statistical analyses. Group values were compared using oneway analysis of variance with Duncan's multiple-range test. Secretory parameters were log-transformed because they are not normally distributed (10) . Univariate linear regression analysis was used to assess correlations. Statistical significance was accepted at a p value of <0.05. Results are reported as mean + SEM.
RESULTS
The clinical characteristics of all the study groups are displayed in Table 1 . The average chronologic and skeletal ages were for the SHORT-DBA group compared with those of both other groups. Values for height SDS and growth velocity SDS for both the SHORT and SHORT-DBA groups were significantly ( p < 0.00 1 and p < 0.0 1, respectively) less than those of the NORMAL subjects but indistinguishable from each other.
Typical profiles obtained by deconvolution analysis are shown in Figure 1 ; a representative reconvolved serum G H concentration versus time graph and a G H secretory rate versus time curve are illustrated for each group. The numerical results of deconvolution analysis for the three study groups are listed in Table 2 .
The secretory burst half-duration (time interval of the secretory event at half-maximal amplitude) of the SHORT-DBA subjects groups were indistinguishable. The mean 12-h serum G H concentrations, secretory burst frequencies, and 12-h GH production rates [expressed as mass of G H per unit of body distribution volume (L,), mass of G H per unit of body surface area, or mass of GH/kg of body mass] were indistinguishable among the study groups. Comparisons of secretory burst frequency, mass of GH released per secretory burst, maximal rate of hormone secretion, and G H production rate are depicted in Figure 2 . Endogenous GH half-life estimates were indistinguishable among the study groups; the derived estimates are in general agreement with independently obtained values in adults and children (16) (17) (18) (19) (20) .
Shown in Table 3 are the results of linear-regression analysis for several GH secretion characteristics and BA SDS for all subjects combined. Significant correlations were observed between secretory burst half-duration ( r = -0.41, p = 0.02), the mass of GH released per secretory episode ( r = 0.43, p = 0.02), and maximal rate of G H secretion attained within a burst (amplitude) ( r = 0.46, p = 0.01) versus BA SDS. The relationships between BA SDS and the mass of G H released per secretory burst and the rate of G H secretion are illustrated in Figure 3 . No significant relationship was observed between G H production rate ( r = 0.24, p = 0.20) and BA SDS. is an important signal for the control of growth (22) . As such, these findings underscore the important role of the pulsatile pattern of GH secretion in the modulation of normal childhood growth. However, the precise role and characteristics of pituitary GH secretion and metabolic clearance of the G H molecule in the modulation of growth in otherwise healthy short children has not been fully addressed.
We have therefore applied deconvolution analysis to determine if alterations in pituitary G H secretion and the consequent hormone production rate or in hormone clearance exist in a group of healthy, short, prepubertal males. Multiple-parameter deconvolution analysis is a computerized mathematical technique that, when applied to deconvolutional hormone concentration versus time series, provides subject-specific estimates of hormone secretion and elimination characteristics. Thus, the application of this mathematical technique provides mechanistic insight into the kinetics of the secretory events and the metabolic clearance of the G H molecule.
In the present study, average circulating levels of G H did not differ among the groups. Different mechanisms of hormone secretion, however, were existent. In the short subjects with delayed skeletal maturation, the average duration of G H secretory episodes was prolonged compared with the other short subjects. This abnormality has also been observed recently in young girls with Turner's syndrome (23) . A diminished mass of G H released per secretory episode and a decreased average maximal rate of hormone secretion were observed in the same subjects. Although a trend toward decreased 12-h GH production rates was observed for the SHORT-DBA group, the results did not achieve statistical significance. The prolonged duration of secretion and trends toward a greater secretory burst frequency and a lengthened hormone half-life, both of which have been recognized in prepubertally aged girls with Turner's syndrome (above), would contribute to increased circulating G H concentrations. The decreased mass of hormone released per burst and diminished rate of G H release, however, would result in lowered G H levels. The net result of these simultaneously acting mechanisms is an invariant average concentration of spontaneously circulating GH and unaltered G H production rates.
The findings of the present study provide some insight into the pathophysiology of altered G H secretion and suboptimal growth in a subset of healthy, prepubertal males with constitutional delayed growth. The pulsatile pattern of G H secretion arises from episodic increases and decreases in the release and subsequent action of GHRH and SRIH on the somatotrope (24, 25) . In the simplest interpretation of available data, the amount of GHRH released determines the amount of G H released per secretory episode and the pattern of SRIH action determines the frequency and duration of the G H secretory bursts (26-28).
The findings of the present study support the concept that a relative deficiency of the amount of GHRH released per burst (but not the indirectly inferred frequency of GHRH bursts) plays an important role in the altered GH secretion observed in prepubertal males with constitutional delay of growth. In support of this concept are the diminished mass of G H released per burst and a decreased maximal rate of hormone release. Although these findings might also be explained by heightened SRIH tone, additional evidence in support of altered GHRH action is derived from presumptive inhibition of SRIH secretion by P-adrenergic blockade. Spontaneous release of G H fails to rise after administration of atenolol, a @-adrenergic blocking agent, to healthy, prepubertal males with constitutional delay of growth (29). These data suggest that perturbed GHRH action, rather than disturbance of SRIH effect, plays a critical role in the altered G H secretion in prepubertal males with constitutional delayed growth. The increased secretory burst duration, however, may not be due entirely to altered GHRH action. There are likely direct GHRH-SRIH interactions within the hypothalamus (30). The consequence of a disruption of these normal interactions may be manifested as altered rate and/or duration of hormone secretion and, conceivably, altered frequency of G H secretory episodes. Of interest, an increased frequency of low-amplitude GH secretory bursts has been described recently as a statistically positive predictor of clinical linear-growth responses to G H administration in Turner's syndrome (3 1).
The sex-steroid hormones are known to significantly alter GH secretion (32, 33) . By definition, subjects with constitutional delayed growth and adolescence have a prolonged period of relative sex-steroid hormone insufficiency. One may speculate that the apparent (and relative) deficiency of GHRH in our subjects with constitutional delay is the result of this suboptimal action of gonadal steroid hormones in the prepubertal period. In support of such a relationship is the ability of very small doses of estrogen to increase G H secretion 2-to 3-fold in prepubertal girls with Turner's syndrome (34) . Administration of androgen to young males with constitutional delay of growth and adolescence results in augmented G H secretion (35) . Specifically, both the mass and maximal rate of G H released per secretory episode were increased in these subjects. Saggese et a/. (36) have recently reported decreased circulating concentrations of GHRH in prepubertal subjects with constitutional delayed development. No such abnormality was observed in these subjects during adolescent development, a time of augmented sex-steroid hormone levels. No alterations in peripheral SRIH concentrations were observed. Although of interest, the precise relevance of such measurements to changes in the levels of GHRH and SRIH in hypophyseal portal blood remains to be tested.
Recently, Veldhuis et a/. (37) used deconvolution analysis to quantitate pituitary G H secretion and circulating G H half-life in a group of healthy, prepubertal males with idiopathic short stature. No differences were noted, however, for any characteristics of hormone secretion or of the estimated, subject-specific half-lives. Although no apparent mathematical relationship was observed between various specific quantitative parameters of GH KERRIGAN secretion and skeletal age, those subjects with significantly delayed bone ages were not evaluated separately and constituted a small percentage of the group. Thus, inferences concerning the mode of GH secretion in subjects with constitutional delayed growth and development in that study are not possible.
In summary, 12-h overnight GH production rates for healthy, short, prepubertal males did not differ from values for control subjects of normal stature. In a subset of short boys with constitutional delay of growth (i.e. those short boys with significantly delayed bone age), however, several characteristics of GH secretion were altered; among these were decreased mass of hormone released per secretory burst, prolonged GH secretion episodes, and diminished maximal rate of GH secretion attained within each burst. The frequency of GH secretory burst and the endogenous GH half-life were invariant. The observed alterations in GH secretory dynamics may underlie the suboptimal growth in some prepubertal males with constitutional delay of growth and provide insight into the neuroendocrine mechanisms subserving such altered GH physiology.
